Who Paid My Doc Search
Menu
Organisation paid for research Program year 2021 Source: CMS Open Payments

Beacon Medcl GRP

Neither a doctor nor a teaching hospital

Research payments

$55,384

112 payments

Through program year 2021, Beacon Medcl GRP is reported as receiving $55,384 in research payments, across 112 payments.

By program year

3 rows
Year Kind Amount Payments
2021 Research $2,939 8
2020 Research $6,015 22
2019 Research $46,430 82

Breakdown

Who paid Research payments · program years 2019–2021
  1. Boehringer Ingelheim Pharma GmbH & Co.KG $31,514 10 payments
  2. Boehringer Ingelheim International GmbH $18,905 100 payments
  3. Boehringer Ingelheim Pharmaceuticals, Inc. $4,965 2 payments
Studies the money was for Research payments · program years 2019–2021
  1. Empagliflozin and heart failure (HFpEF) $32,959 55 payments
  2. Empagliflozin and Heart failure (HFrEF) $17,460 55 payments
  3. GLORIA AF Registry Phase II III Core $4,965 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record